L’allo-immunisation érythrocytaire fœtomaternelle dans le système ABO reste la principale cause des maladies hémolytiques du fœtus et du nouveau-né. Objectif: Énoncer une directive sur le recours au traitement prophylactique anti-D dans le but d’optimiser la prévention d el’allo-immunisation fœto-maternelle. Prévention de l’allo-immunisation fœto-maternelle Rh: en sommes-nous là? Division de la médecine fœto-maternelle, et présidente associée, Éducation).
|Published (Last):||9 May 2017|
|PDF File Size:||15.93 Mb|
|ePub File Size:||11.66 Mb|
|Price:||Free* [*Free Regsitration Required]|
Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care. Vigilance is even more important for infants discharged before the age of 72 h. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website’s visitors, including their identity, is confidential. We report on three cases showing that ABO allo-immunization can lead to severe hemolytic disease of the newborn with potentially threatening hyperbilirubinemia and complications. Contact Help Who are we?
There was a problem providing the content you requested
Intensity is generally lower than in RhD allo-immunization. You can move this window by clicking on the headline. Contact Help Who are we? However, despite a great deal of progress, we should not maternelel sight of the fact that these tests give only an indirect measurement and will only help the obstetrician, in conjunction with other fetal parameters, to assess the severity of the haemolytic disease HD maternell the fetus and newborn.
Access to the full text of this article requires a subscription. As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.
Transfert des anticorps maternels vers le foetus. Outline Masquer le plan. A direct antiglobulin test is the cornerstone of diagnosis and should be performed at birth on cord blood sampling in all group infants born to O mothers, especially if of African origin.
Allo-immunisation fœto-maternelle anti-CD10
Access to the text HTML. Journal page Archives Contents list.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties. Access to the full text of this article requires a subscription. If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. You can move this window by clicking on the headline. Early diagnosis and adequate care are necessary to prevent complications in ABO incompatibility. Phototherapy and, in ummunisation cases, exchange transfusion are used to prevent hyperbilirubinemia encephalopathy.
Every newborn should be assessed for the risk of developing severe hyperbilirubinemia and should be examined by a qualified healthcare immnuisation in the first days of life. Haemolytic disease of the fetus and newborn ; Detection of irregular antibodies ; Antibody titration ; Anti-rh quantitation ; RHD genotyping.
Top of the page – Article Outline. Personal information regarding our website’s visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Access to the PDF text. Access to the PDF text. Outline Masquer le plan. The best method to assess the severity is the direct determination of foetal aplo group hemoglobin after foetal blood sampling but this procedure is not without risk. Since 10 years ago, it is possible to determine maernelle RHD genotype of the fetus using amniocytes and, today, maternal plasma directly.
The trend in anti-RH levels is more important than the level itself. If you want to aloo to this journal, see our rates You can purchase this item in Pay Per View: Treatments of severe hemolytic disease of the newborn should be provided and performed by trained personnel in neonatal intensive care units.
Immunohaematological tests used in antenatal patients have come a long way. Treatment depends on the total serum bilirubin level, which may increase very rapidly in the first 48 h of life in cases of hemolytic disease of the newborn.
Minon bJ. Access to the text HTML.